nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acute kidney injury in acute on chronic liver failure
|
Maiwall, Rakhi |
|
2015 |
10 |
2 |
p. 245-257 |
artikel |
2 |
Advances in therapeutics for chronic hepatitis B
|
Yang, Ninghan |
|
2015 |
10 |
2 |
p. 277-285 |
artikel |
3 |
Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection
|
Yang, Sheng-Shun |
|
2015 |
10 |
2 |
p. 258-266 |
artikel |
4 |
Effects of long-term entecavir treatment on the incidence of hepatocellular carcinoma in chronic hepatitis B patients
|
Watanabe, Takao |
|
2015 |
10 |
2 |
p. 320-327 |
artikel |
5 |
Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan
|
Wang, Chia-Chi |
|
2015 |
10 |
2 |
p. 294-301 |
artikel |
6 |
Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study
|
Assem, M. |
|
|
10 |
2 |
p. 377-385 |
artikel |
7 |
Efficacy and safety of alternating norfloxacin and rifaximin as primary prophylaxis for spontaneous bacterial peritonitis in cirrhotic ascites: a prospective randomized open-label comparative multicenter study
|
Assem, M. |
|
2015 |
10 |
2 |
p. 377-385 |
artikel |
8 |
Essential components in developing public policy to control viral hepatitis: lessons from Taiwan
|
Wallace, Jack |
|
2015 |
10 |
2 |
p. 355-362 |
artikel |
9 |
Evaluating the living donor: expansion by innovation
|
Lo, Chung-Mau |
|
2016 |
10 |
2 |
p. 242-244 |
artikel |
10 |
High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study
|
Petersen, Tess |
|
2015 |
10 |
2 |
p. 310-319 |
artikel |
11 |
High FIB-4 index as an independent risk factor of prevalent chronic kidney disease in patients with nonalcoholic fatty liver disease
|
Xu, Huang-Wei |
|
2015 |
10 |
2 |
p. 340-346 |
artikel |
12 |
Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back
|
Xu, Chengfu |
|
2015 |
10 |
2 |
p. 286-293 |
artikel |
13 |
Low expression of N-myc downstream-regulated gene 2 (NDRG2) correlates with poor prognosis in hepatoblastoma
|
Gödeke, Jan |
|
2015 |
10 |
2 |
p. 370-376 |
artikel |
14 |
Non-invasive assessment of portal hypertension and liver fibrosis using contrast-enhanced ultrasonography
|
Maruyama, Hitoshi |
|
2015 |
10 |
2 |
p. 267-276 |
artikel |
15 |
Oral antiviral therapy reduces the risk of hepatocellular carcinoma in persons with chronic hepatitis B infection: combining evidence and common sense
|
Kong, Yuanyuan |
|
2016 |
10 |
2 |
p. 239-241 |
artikel |
16 |
Percutaneous recanalization for hepatic vein-type Budd-Chiari syndrome: long-term patency and survival
|
Cui, Yan-Feng |
|
2015 |
10 |
2 |
p. 363-369 |
artikel |
17 |
Tenofovir rescue therapy in chronic hepatitis B patients who failed previous nucleoside analogue treatment
|
Kozielewicz, Dorota |
|
2015 |
10 |
2 |
p. 302-309 |
artikel |
18 |
The arterial tumor enhancement pattern on contrast-enhanced computed tomography is associated with primary cancer death after radiofrequency ablation for small hepatocellular carcinoma
|
Shimizu, Ryo |
|
2015 |
10 |
2 |
p. 328-339 |
artikel |
19 |
The impact of metabolic syndrome and prevalent liver disease on living donor liver transplantation: a pressing need to expand the pool
|
Al-hamoudi, Waleed |
|
2015 |
10 |
2 |
p. 347-354 |
artikel |